Finomel Emulsion for Infusion (42% glucose, 10% amino acid, 20% lipid): Interim Supply of Belgian Stock to Mitigate Supply Disruption

To ensure continuity in supply during the current Covid-19 situation, Baxter has obtained approval from MHRA to supply a Belgian product which is expected to be on the UK market from June to Dec 2020. The product from Belgium has the same formulation as the UK product.